Are you Dr. Eltzschig?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 49 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6431 Fannin St
Houston, TX 77030Phone+1 713-500-6222Fax+1 713-500-0730- Is this information wrong?
Summary
- Dr. Holger Eltzschig, MD is a board certified anesthesiologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Colorado, and Massachusetts. He is affiliated with Memorial Hermann - Texas Medical Center and is a Professor at University of Colorado School of Medicine.
Education & Training
- Brigham and Women's HospitalResidency, Anesthesiology, 1999 - 2002
- Eberhard Karls University Faculty of MedicineClass of 1996
Certifications & Licensure
- CO State Medical License 2007 - 2025
- MA State Medical License 2002 - 2025
- TX State Medical License 2017 - 2024
- American Board of Anesthesiology Anesthesiology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- The BMAL1/HIF2A heterodimer modulates circadian variations of myocardial injury.Wei Ruan, Tao Li, Jaewoong Lee, In Hyuk Bang, Wankun Deng, Xinxin Ma, Seung-Hee Yoo, Boyun Kim, Jiwen Li, Xiaoyi Yuan, Yu A An, Yin-Ying Wang, Yafen Liang, Matthew Deb...> ;Research Square. 2024 Feb 28
- The hepatokine orosomucoid 2 mediates beneficial metabolic effects of bile acids.Lee, S., Suh, J., Heo, M., Choi, J., Yang, Y., Jung, H., Gao, Z., Yongmei, Y., Jung, S., Kolonin, M., Cox, A., Hartig, S., Ju, C., Moore, D., Kim, K., Eltzschig, H.> ;Diabetes. 2024 Feb 6
- Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome.Katherine Figarella, Jieun Kim, Wei Ruan, Tingting Mills, Holger Klaus Eltzschig, Xiaoyi Yuan> ;Frontiers in Immunology. 2024 Jan 1
- Join now to see all
Authored Content
- Anesthetic Drugs and Cancer Progression: Fact or FictionAugust 2020
Press Mentions
- DOD Injects $5.1m into Clinical Trial Investigating Novel Oral Therapy to Treat ARDS Associated with COVID-19January 14th, 2021
- Researchers Receive $5.1 Million to Expand Clinical Trial of Drug to Prevent ARDS in COVID-19 PatientsJanuary 13th, 2021
- GATA Factor-Regulated Solute Carrier Ensemble Reveals a Nucleoside Transporter-Dependent Differentiation MechanismDecember 28th, 2020
- Join now to see all
Hospital Affiliations
- Memorial Hermann - Texas Medical CenterHouston, Texas